Salud financiera de hoja de balance de Vincerx Pharma
Salud financiera controles de criterios 4/6
Vincerx Pharma has a total shareholder equity of $15.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $21.5M and $6.1M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$16.32m |
| Patrimonio | US$15.45m |
| Total pasivo | US$6.08m |
| Activos totales | US$21.53m |
Actualizaciones recientes sobre salud financiera
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Sep 22Recent updates
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Sep 22Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?
Jun 24Vincerx Pharma doses first patient in early-stage VIP152 cancer study
Jun 03Análisis de la situación financiera
Pasivos a corto plazo: VINC's short term assets ($18.3M) exceed its short term liabilities ($5.3M).
Pasivo a largo plazo: VINC's short term assets ($18.3M) exceed its long term liabilities ($747.0K).
Historial y análisis de deuda-patrimonio
Nivel de deuda: VINC is debt free.
Reducción de la deuda: VINC had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: VINC has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: VINC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 32.5% each year